Inhaltsseite: Home

Thursday, 21 April 2022
Reading time : 2 minutes
Yield Enhancement

Weak first quarter: RCs on potential catch-ups

The first stock market quarter of 2022 was characterized by rising inflation, rising interest rates and geopolitical uncertainties, which had a noticeable impact on the performance of the stock markets. Year-to-date, i.e. from January 1, 2022 to the present, no Western benchmark index was able to break even. The Euro Stoxx 50 stands at -8.5%, the S&P 500 at -6.7% and the SMI at -3.8%.

Friday, 1 April 2022
Reading time : 1 minute
Yield Enhancement

Swiss Underlyings: Yield with BRC

Swiss equities are among the most popular underlyings for structured products - also for yield-optimizing BRC

Friday, 25 March 2022
Reading time : 1 minute
Yield Enhancement

Growth & Yield: Chinese Tech and Bio-Pharma

For yield enhancement products, increased volatility leads to higher coupons - especially for (C)BRC this is interesting, because despite very low barriers coupons above 15% p.a. can be realized.

Friday, 25 March 2022
Reading time : 1 minute
Yield Enhancement

Low correlations: 8% p.a. with 50% barrier

If underlyings with low correlations are selected for BRC, the probability of a barrier event increases, but so does their return potential; in combination with the still slightly increased volatility, attractive return profiles result even for very defensive barriers and over-the-year maturities.

Wednesday, 16 March 2022
Reading time : 1 minute
Yield Enhancement

SMI BRC with Last Look

"Last Look BRC" have the characteristic that the barrier is only considered at the expiration of the BRC - shorter-term price declines, where the barrier is temporarily undercut, have no effect on the payout, provided that the price of the underlying is again above the barrier level at maturity; in this case, investors:inside receive a full repayment. So if turbulent markets are expected in the coming months, products with Last Look feature may be suitable to reduce the risk compared to "classic" BRCs.

Tuesday, 15 March 2022
Reading time : 2 minutes
Yield Enhancement

Countercyclical underlyings: BRC with pharma stocks

Unlike many sectors, pharmaceutical companies are among the so-called anti-cyclicals. While their share prices often rise less strongly in boom times than those of cyclical stocks, they demonstrate their defensive qualities in more difficult market situations. Stable earnings and comparatively reliable dividend growth support the share prices of companies whose products sell even in times with an uncertain market outlook.

Friday, 11 March 2022
Reading time : 1 minute
Wednesday, 2 March 2022
Reading time : 2 minutes
Yield Enhancement

European Barrier: Defensive BRC in Moving Markets

Instability continues to move the global markets, and high equity volatility is unsettling conservative investors. In such market situations, structured products with defensive parameters are particularly suitable for adjusting the risk-return ratio to the increased volatility.

Friday, 25 February 2022
Reading time : 1 minute
Yield Enhancement

Defensive parameters in volatile markets

In turbulent markets and an uncertain outlook, more conservative investment solutions are in demand. Barrier Reverse Convertibles with defensive parameters offer interesting return opportunities even with lower risk.


Ajax loading